Tumours frequently express BRAF mutations (> 80%), specifically the V600E mutation (Fig. 1) [15], which has an activating missense mutation in codon 600 of exon 15 of the BRAF gene, leading to constitutive activation of the MAPK pathway, resulting in increased cellular proliferation and decreased apoptosis [15]. This evidence concerns the gene BRAF and neoplasm.